Department of Neuroradiology, Foundation Adolphe de Rothschild Hospital, 25 rue Manin, 75019, Paris, France.
Department of Orbitopalpebral Surgery, Foundation Adolphe de Rothschild Hospital, 25 rue Manin, Paris, 75019, France.
Eur Radiol. 2021 Jul;31(7):5198-5205. doi: 10.1007/s00330-020-07540-y. Epub 2021 Jan 6.
To determine the diagnostic performances of a single Dixon-T2-weighted imaging (WI) sequence compared to a conventional protocol including T1-, T2-, and fat-suppressed T2-weighted MRI at 3 T when assessing thyroid eye disease (TED).
This IRB-approved prospective single-center study enrolled participants presenting with confirmed TED from April 2015 to October 2019. They underwent an MRI, including a conventional protocol and a Dixon-T2WI sequence. Two neuroradiologists, blinded to all data, read both datasets independently and randomly. They assessed the presence of extraocular muscle (EOM) inflammation, enlargement, fatty degeneration, or fibrosis as well as the presence of artifacts. The Wilcoxon signed-rank test was used.
Two hundred six participants were enrolled (135/206 [66%] women, 71/206 [34%] men, age 52.3 ± 13.2 years). Dixon-T2WI was significantly more likely to detect at least one inflamed EOM as compared to the conventional set (248/412 [60%] versus 228/412 [55%] eyes; (p = 0.02). Dixon-T2WI was more sensitive and specific than the conventional set for assessing muscular inflammation (100% versus 94.7% and 71.2% versus 68.5%, respectively). Dixon-T2WI was significantly less likely to show major or minor artifacts as compared to fat-suppressed T2WI (20/412 [5%] versus 109/412 [27%] eyes, p < 0.001, and 175/412 [42%] versus 257/412 [62%] eyes, p < 0.001). Confidence was significantly higher with Dixon-T2WI than with the conventional set (2.35 versus 2.24, p = 0.003).
Dixon-T2WI showed higher sensitivity and specificity and showed fewer artifacts than a conventional protocol when assessing thyroid eye disease, in addition to higher self-reported confidence.
• Dixon-T2WI has better sensitivity and specificity than a conventional protocol for assessing inflamed extraocular muscles in patients with thyroid eye disease. • Dixon-T2WI shows significantly fewer artifacts than fat-suppressed T2WI. • Dixon-T2WI is faster and is associated with significantly higher self-reported reader confidence as compared to a conventional protocol when assessing inflammatory extraocular muscles.
在 3T 磁共振成像(MRI)中,评估甲状腺眼病(TED)时,与常规 T1、T2 和脂肪抑制 T2 加权成像(WI)序列相比,单次 Dixon-T2WI 序列的诊断性能。
这项经机构审查委员会批准的前瞻性单中心研究纳入了 2015 年 4 月至 2019 年 10 月期间确诊为 TED 的患者。他们接受了 MRI 检查,包括常规序列和 Dixon-T2WI 序列。两名神经放射科医生独立且随机地对这两种数据集进行了盲法阅读。他们评估了眼外肌(EOM)炎症、肿大、脂肪变性或纤维化以及伪影的存在。采用 Wilcoxon 符号秩检验。
共纳入 206 名参与者(135/206 [66%] 为女性,71/206 [34%] 为男性,年龄 52.3±13.2 岁)。与常规组相比,Dixon-T2WI 更有可能检测到至少一个炎症性 EOM(248/412 [60%] 比 228/412 [55%] 眼;(p=0.02)。Dixon-T2WI 对评估肌肉炎症的敏感性和特异性均高于常规组(100%比 94.7%和 71.2%比 68.5%)。与脂肪抑制 T2WI 相比,Dixon-T2WI 出现主要或次要伪影的可能性显著更低(20/412 [5%] 比 109/412 [27%] 眼,p<0.001,和 175/412 [42%] 比 257/412 [62%] 眼,p<0.001)。与常规组相比,Dixon-T2WI 的置信度显著更高(2.35 比 2.24,p=0.003)。
Dixon-T2WI 在评估甲状腺眼病时,与常规方案相比,显示出更高的敏感性和特异性,并且出现伪影的情况更少,此外报告的信心更高。
Dixon-T2WI 对评估甲状腺眼病患者的炎症性眼外肌的敏感性和特异性优于常规方案。
Dixon-T2WI 与脂肪抑制 T2WI 相比,伪影明显更少。
Dixon-T2WI 与常规方案相比,评估炎症性眼外肌时速度更快,并且自我报告的读者信心显著更高。